Results 41 to 50 of about 38,327 (259)

Spontaneous heparin-induced thrombocytopenia presenting as bilateral adrenal hemorrhages and pulmonary embolism after total knee arthroplasty

Arthroplasty Today, 2015
Heparin-induced thrombocytopenia syndrome is an acquired potentially life-threatening prothrombotic disorder caused by antibodies that recognize complexes of platelet factor 4 bound to heparin or heparin-like molecules. It typically occurs after exposure
Amro Elshoury, MBChB, Maha Khedr, MBChB, Mostafa M. Abousayed, MD, Syed Mehdi, MD   +3 more
doaj   +1 more source

Successful Use of Intravenous Immunoglobulin G to Treat Refractory Heparin-Induced Thrombocytopenia With Thrombosis Complicating Peripheral Blood Stem Cell Harvest

Journal of Investigative Medicine High Impact Case Reports, 2018
Heparin-induced thrombocytopenia is a well-known, life-threatening complication that occurs in 5% of patients exposed to heparin. It causes thrombocytopenia in roughly 85% to 90% of affected individuals, with expected recovery in approximately 4 to 10 ...
Devon S. McKenzie MD, Josephine Anuforo MD, Jennah Morgan MD, Elvira Neculiseanu MD   +3 more
doaj   +1 more source

Deterioration of vaccine‐induced immune thrombotic thrombocytopenia treated by heparin and platelet transfusion: Insight from functional cytometry and serotonin release assay

Research and Practice in Thrombosis and Haemostasis, 2021
We report a case of a 62‐year‐old man who developed cerebral venous sinus thrombosis with subarachnoid hemorrhage and concomitant thrombocytopenia, which occurred 13 days after ChAdOx1 nCov‐19 injection.
Alice Bérezné, David Bougon, Florence Blanc‐Jouvan, Nicolas Gendron, Cecile Janssen, Michel Muller, Sébastien Bertil, Florence Desvard, Isabelle Presot, Benjamin Terrier, Richard Chocron, Olivier Sanchez, Dominique Helley, David M. Smadja   +13 more
doaj   +1 more source

Thrombocytopeniak. [PDF]

, 2014
Thrombocytopenia means low platelet count. This is the most frequent cause of bleeding abnormalities. Petechias, purpuras, mucosal bleeding are typical clinical findings.
Domján, Gyula, Gadó, Klára
core   +1 more source

Case Report: Heparin-induced thrombocytopenia during COVID-19 outbreak: the importance of scoring system in differentiating with sepsis-induced coagulopathy [version 1; peer review: 2 approved]

F1000Research, 2021
Background: COVID-19 disease is accompanied by derangement of coagulation with a risk of fatal thromboembolic formation. COVID-19 patients are among those indicative for heparin treatment.
Louisa Fadjri Kusuma Wardhani, Ivana Purnama Dewi, Denny Suwanto, Meity Ardiana   +3 more
doaj   +1 more source

Intracapillary leucocyte accumulation as a novel antihaemorrhagic mechanism in acute pancreatitis in mice [PDF]

, 2009
Background: Pancreatic infiltration by leucocytes represents a hallmark in acute pancreatitis. Although leucocytes play an active role in the pathophysiology of this disease, the relation between leucocyte activation, microvascular injury and haemorrhage
Deduchovas, O., Hartwig, W., Kerkadze, V., Märten, A., Parseliunas, A., Ryschich, E., Salnikova, O., Schmidt, J., Sperandio, Markus   +8 more
core   +1 more source

Heparin-induced thrombocytopenia: an update

Thrombosis Journal, 2005
Heparin-induced thrombocytopenia (HIT) is the most important and most frequent drug-induced, immune-mediated type of thrombocytopenia. It is associated with significant morbidity and mortality if unrecognized.
Franchini Massimo
doaj   +1 more source

Heparin-induced thrombocytopenia following coronary artery bypass grafting: a diagnostic dilemma [PDF]

Journal of Community Hospital Internal Medicine Perspectives, 2015
The diagnosis of heparin-induced thrombocytopenia (HIT) is a challenge in post-cardiac surgery patients because of the high incidence of non-immune thrombocytopenia and heparin–platelet factor 4 antibodies in these groups.
Raju Khanal, Paras Karmacharya, Daniel A. Forman   +2 more
doaj   +1 more source

Angiotensin II type 1 receptor blocker-induced immune thrombocytopenia: a case report [PDF]

, 2013
INTRODUCTION: The development of thrombocytopenia after a dose increase in losartan and subsequently after switching the patient to valsartan is reported.
David Schnee, Dhiren K. Patel, Nikhil Bilkha   +2 more
core   +1 more source

Delayed‐onset heparin‐induced thrombocytopenia complicated with saddle embolus

Clinical Case Reports, 2022
Delayed‐onset heparin‐induced thrombocytopenia is a rare complication of heparin in which thrombocytopenia and thrombosis occur several days after heparin cessation.
Faezeh Sadat Naji, Mahan Shafie, Mahbod Issaiy, Narjes Zarei Jalalabadi, Samaneh Parsa   +4 more
doaj   +1 more source